AMIT 301 - our first commercial device | fda class 1

SUCCESSFUL CLINICAL RESULTS

Detecting Large Vessel Occlusions (LVO) Onset during Balloon Occlusion (n=67)

AI learned personalized baseline hemodynamic activity

Continuously outputs an LVO probability

Alarm triggered above individualized threshold

Using 40% threshold probability, 100% accuracy LVOs detected. No false alarms

Clinical Validation

NEWS AND publications

Avertto Updates

Publications

OUR values

Avertto Management Code

Positive Mindset: Giving. Gratitude. Hope and Faith. Integrity. Accountability.
Persistence: Grit. Courage. Adventure. Perspective. Ambition.
Proactiveness: Collaboration. Knowledge Sharing. Learning. Caring. Creativity.
Personal: Home. Authenticity. Unique. Well-being.

A SEASONED TEAM

Experts in medical devices, clinical trials, and global business development.

Dr. Hilla Ben-Pazi

MD, Founder & CEO

A senior neurologist with over two decades of experience in clinical studies and collaborative networks, founder and owner of the first tele-neurology company in Israel (2017, NeuroCan). Winner of EIC WomenTech leadership program.

Yaniv Kirma

BSc. EE and Physics,
CTO

Over 25 years of experience in the medical and defense industries in various roles, such as CEO of Endoways, CEO of FiberNova, Co-Founder, VP of R&D, and General Manager at EndoChoice.

Kety Bardugo

BA., ICQE,
Chief Quality & Regulatory Officer

A Quality and Regulatory Affairs expert with 20+ years in the medical device field. Kety specializes in scaling quality frameworks for startups and global firms, guiding products from R&D to market. She leads strategic collaborations with regulatory authorities and notified bodies throughout the entire product lifecycle.

Yair Lavi

BSc.,MSc.,
Algo team leader

Leader of Avertto’s Algo Team, is an experienced algorithms developer and manager with expertise in AI, deep learning, and signal processing on time series data, and has contributed to the success of startups like Tonara, 3DSignals, and Sosense.

Meron Ben Pazi

BA, Product Manager

Meron is a Product Manager with a practical technical background and hands-on R&D experience. He leads requirements, prioritization, and cross-functional delivery while aligning product goals with engineering constraints. He brings expertise in mechanical and electrical systems.

Lior Elmaliach

BA, Clinical team

Lior, a clinical assistant at Avertto, has recently earned her biology degree from Tel Aviv University. She oversees clinical site engagement, ensures the completion of eCRFs, and resolves any issues that arise. Lior maintains close communication with research coordinators on sites, fostering strong personal and technical relationships to ensure the smooth operation of clinical trials.

Avertto honors the memory of Amit Man, a paramedic killed at Kibbutz Be'eri on October 7th, 2023, at just 22 years old. Amit’s journey into medicine began at 10 after her father’s cancer diagnosis, leading her to become a paramedic at 18, alongside a career as an actor, model, and singer.
On Oct 7th, she chose to stay, knowing her help was needed. For seven hours, Amit provided lifesaving care under fire, demonstrating unmatched courage and compassion.
‍
Avertto is a part of the Next October commemoration initiative; Avertto embraces Amit’s legacy—relentless dedication to saving lives. We are inspired by her courage, leadership, and unwavering commitment to helping others, even in the face of danger. Her story reminds us that every moment counts when it comes to health and human life.
‍

WE WOULD BE HAPPY TO HEAR FROM YOU

Dedicated to improving healthcare and patient outcome, please contact us for further information by completing your details below. Our expert team member will contact you shortly

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

monitor.
detect.
alert.

Mission

monitor

Detect

alert

WINDOW OF OPPORTUNITY

Its about time Early Detection and Intervention

AMIT 301 - our first commercial device | fda class 1